David C. Sachs

Insider Reports History

Location
San Diego, CA
Signature
/s/ Philip LoScalzo, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David C. Sachs:

Company Role Class Num Shares Value Price $ Report Date Ownership
ImmunityBio, Inc. Chief Financial Officer Common Stock 240,582 $476,352 $1.98 31 Dec 2025 Direct
ImmunityBio, Inc. Chief Financial Officer Restricted Stock Units 45,602 $278,049 $3.42 31 Dec 2025 Direct
ImmunityBio, Inc. Chief Financial Officer Stock Option (right to buy) 843,750 10 Feb 2025 Direct

Insider Reports Filed by David C. Sachs

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IBRX ImmunityBio, Inc. 31 Dec 2025 3 -$30,561 4 Chief Financial Officer 05 Jan 2026, 18:11
IBRX ImmunityBio, Inc. 22 Feb 2025 3 -$54,241 4 Chief Financial Officer 25 Feb 2025, 21:11
IBRX ImmunityBio, Inc. 10 Feb 2025 2 $0 4 Chief Financial Officer 12 Feb 2025, 20:16
IBRX ImmunityBio, Inc. 31 Dec 2024 3 -$39,437 4 Chief Financial Officer 03 Jan 2025, 16:54
IBRX ImmunityBio, Inc. 22 Feb 2024 2 $0 4 Chief Financial Officer 26 Feb 2024, 16:40
IBRX ImmunityBio, Inc. 31 Jan 2024 3 -$90,166 4 Chief Financial Officer 02 Feb 2024, 19:33
IBRX ImmunityBio, Inc. 31 Dec 2023 3 -$52,765 4 Chief Financial Officer 03 Jan 2024, 21:41
IBRX ImmunityBio, Inc. 01 Sep 2023 2 $0 4 Chief Financial Officer 06 Sep 2023, 19:41
IBRX ImmunityBio, Inc. 25 Aug 2023 1 $0 4 Chief Financial Officer 28 Aug 2023, 20:58
IBRX ImmunityBio, Inc. 31 Dec 2022 2 $0 4 Chief Financial Officer 04 Jan 2023, 20:49
IBRX ImmunityBio, Inc. 23 Mar 2022 2 $0 4 Chief Financial Officer 25 Mar 2022, 21:05
IBRX ImmunityBio, Inc. 09 Dec 2021 2 $0 4 Chief Financial Officer 13 Dec 2021, 15:15
IBRX ImmunityBio, Inc. 09 Sep 2021 2 $0 4 Chief Financial Officer 13 Sep 2021, 20:34